| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000043655 |
| Receipt No. | R000049853 |
| Scientific Title | Modified Ablation Index: A Novel Determinant of Successful First-Pass Left Atrial Posterior Wall Isolation |
| Date of disclosure of the study information | 2021/03/20 |
| Last modified on | 2022/03/24 (Ver. 2) |
| Basic information | ||
| Public title | Observational study to clarify factors contributing to improved success rate of left atrial posterior wall isolation in patients with atrial fibrillation | |
| Acronym | Study of Success Factors for Left Atrial posterior wall Isolation | |
| Scientific Title | Modified Ablation Index: A Novel Determinant of Successful First-Pass Left Atrial Posterior Wall Isolation | |
| Scientific Title:Acronym | Modified AI as a Determinant of First-Pass LAPWI | |
| Region |
|
|
| Condition | ||
| Condition | Atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose is to examine whether the parameters such as wall thickness, local potential in left atrial posterior wall, and modified AI can be an index for predicting the success of left atrial posterior wall isolation in the patients with atrial fibrillation. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Wall thickness and potential characteristics at left atrial posterior wall between the groups with successful LAPWI and failed LAPWI. |
| Key secondary outcomes | Age, sex, BW, BMI, CHADs2 score, comorbidities, history of atrial fibrillation, renal function, cardiac function, medication content ,and recurrence of atrial fibrillation after ablation between groups with successful LAPWI and failed LAPWI. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Among patients who underwent catheter ablation for atrial fibrillation
(1) Patients who underwent ablation using the CARTO system of the 3D mapping system (2) Patients whose potential in the left chamber can be measured without excess or deficiency |
|||
| Key exclusion criteria | Patients who are judged by the principal investigator to be inappropriate as research subjects | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nihon University School of Medicine | ||||||
| Division name | Division of Cardiology | ||||||
| Zip code | 173-8610 | ||||||
| Address | 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan | ||||||
| TEL | 03-3972-8111 | ||||||
| yasuwo128@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nihon University School of Medicine | ||||||
| Division name | Division of Cardiology | ||||||
| Zip code | 173-8610 | ||||||
| Address | 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan | ||||||
| TEL | 03-3972-8111 | ||||||
| Homepage URL | |||||||
| satoshi.hayashida1@gmail.com | |||||||
| Sponsor | |
| Institute | Nihon University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nihon University School of Medicine |
| Address | 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo, Japan |
| Tel | 03-3972-8111 |
| satoshi.hayashida1@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 55 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Exploratory observational study
Recruitment method: Patients who underwent catheter ablation for atrial fibrillation at our facility in August 2019-February 2020. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049853 |